Company / EPS (Diluted)
Anixa Biosciences Inc EPS (Diluted) History
FY2014-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$0.32
FY2024
5-year range
-$0.79 / $0.45
FY2020-FY2024
Trend
-171.1%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) has fluctuated over the past 10 years, ranging from $-16.00 in FY2016 to $0.45 in FY2023.
Based on SEC 10-K filings.
-0.32 in FY2024.
Improved from $-0.45 to $-0.32 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, eps (diluted) decreased 171.1% year-over-year.
- Peak eps (diluted) was recorded in FY2023.
- Lowest eps (diluted) in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.53 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$0.32 | -171.1% |
| FY2023 | $0.45 | +200.0% |
| FY2022 | -$0.45 | +23.7% |
| FY2020 | -$0.59 | +25.3% |
| FY2019 | -$0.79 | -36.2% |
| FY2018 | -$0.58 | -1.8% |
| FY2017 | -$0.57 | +96.4% |
| FY2016 | -$16.00 | -1354.5% |
| FY2015 | -$1.10 | -2100.0% |
| FY2014 | -$0.05 | -25.0% |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026